
UB373
TargetsTL1A
IndicationsInflammatory bowel disease
ClinicalCN - Early Phase
TherapeuticsImmunology & Inflammation
ModalitiesSmall Molecule
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →